Onderneming Advanced Biomedical Technologies, Inc. Other OTC
Aandelen
ABMT
US00752M1018
Geavanceerde medische apparatuur & technologie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Polymer Osteosynthesis Devices
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +58,30% |
Verkoop per regio
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +58,30% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hui Wang
CEO | Chief Executive Officer | 54 | - |
Kai Gui
DFI | Director of Finance/CFO | 54 | - |
Chi Ming Yu
CHM | Chairman | 50 | - |
Jin Hua Zeng
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sheng Puyi
CTO | Chief Tech/Sci/R&D Officer | 56 | 01-03-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chi Ming Yu
CHM | Chairman | 50 | - |
Hui Wang
CEO | Chief Executive Officer | 54 | - |
Kai Gui
DFI | Director of Finance/CFO | 54 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 70 904 850 | 68 554 850 ( 96,69 %) | 0 | 96,69 % |
Bedrijfsgegevens
Advanced BioMedical Technologies, Inc.
535 Fifth Avenue 4th floor
10017, New York
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,73% | 226 mld. | |
+9,53% | 188 mld. | |
+14,63% | 137 mld. | |
+27,47% | 108 mld. | |
-0,04% | 63,19 mld. | |
+13,73% | 52,26 mld. | |
+4,86% | 51 mld. | |
+7,72% | 43,89 mld. | |
+7,86% | 38,07 mld. |